Teyssedou Lenaic Nathanael disposed of 602,908 derivative securities and was awarded 602,908 derivative securities in Addex Therapeutics Ltd. transactions dated 2026-09-02, each at $0 per share. For investors, the key distinction is that the two transaction sets carry different reported post-transaction ownership totals.

Key Highlights

  • The transactions were dated 2 September 2026 and carried a stated price of $0 per share.
  • Teyssedou Lenaic Nathanael is identified as Addex Therapeutics Ltd.’s principal accounting officer.
  • Reported post-transaction holdings were 502,423 derivative securities after the disposals and 602,908 after the awards.

Teyssedou Lenaic Nathanael completed two sets of derivative-security transactions involving Addex Therapeutics Ltd. with each set covering 602,908 securities. The records show both disposals and awards, creating separate post-transaction ownership figures for the principal accounting officer.

Addex Derivative-Security Transactions Recorded

The transactions took place on 2 September 2026, with each priced at $0 per share. Teyssedou Lenaic Nathanael disposed of 602,908 derivative securities through 8 separate transactions. Those awards carried transaction code A. Teyssedou Lenaic Nathanael is identified as Addex Therapeutics Ltd.’s principal accounting officer.

Following the disposals, Teyssedou Lenaic Nathanael’s reported ownership stood at 502,423 derivative securities. Following the awards, the reported ownership was 602,908 derivative securities. The ownership totals are tied to separate transaction sets.